18 defendants charged in $490M worth of alleged COVID-19 fraud schemes

The Justice Department is charging 18 defendants in separate COVID-19-related fraud schemes, in the largest coordinated law enforcement action targeting COVID-19 healthcare fraud to date. 

Advertisement

The cases collectively amount to an alleged $490 million in false billing and theft from federal COVID-19 programs, according to an April 20 news release from the Justice Department. 

According to the release, multiple defendants were charged with defrauding the Health Resources and Services Administration COVID-19 Uninsured Program, which provides access to COVID-19 testing and treatment. 

In California, a lab owner faces charges for allegedly submitting over $358 million in false claims to Medicare, the COVID-19 uninsured program, and a private insurance company. 

A California physician was charged for allegedly orchestrating $230 million in fraudulent billing to the federal government’s uninsured program. 

Other individuals in multiple states were charged for allegedly creating and selling counterfeit COVID-19 vaccination cards. 

Read more about the enforcement actions here. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.